Cardiometabolic Brand Strategy Sr. Associate at Eli Lilly and Company

Mexico City, Mexico City, Mexico

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Willing to disrupt the cardiometabolic market in Mexico and turn great ideas and customer insights into winning strategies
Capable of discussing scientific information without being a physician and having high-level conversations with Health Care Providers (HCPs)
Strong organizational skills and time management
Puts the patient at the center of everything and makes the right decision, not the easy one
Willing to adapt, innovate, and accelerate in a changing and competitive environment
Delivers consistently
100% customer-centered
Adaptability
Strong project management skills - ability to execute on a plan and manage multiple deadlines/priorities
Problem-solving skills
Strong communication skills, both verbal and written
Empathy and emotional intelligence
Critical and strategic thinking
Influence
Learning agility

Responsibilities

Promotional Liaison for Top Prescribers: VBS and Mounjaro Obesity expert, 100% confident in applying aspects of the selling model to customer interactions
Provide field perspectives and bring customer insights from key players
Influence marketing and medical teams to integrate the most relevant insights into brand solutions (e.g., messaging, educational initiatives, promotional events)
Speakers MX Cardiometabolic Affiliate Operation: Accountable for all Sales Force activities that involve a transfer of value to speakers
Ensure 100% of speakers are aligned with strategy and master the brand strategy
Make decisions based on business acumen to fulfill the program objective (e.g., selecting speakers according to HCPs segment)
Develop a measurement plan for all activities from targeting to knowledge impact measurement
Comply 100% with all policies and procedures from speakers’ selection to payment
Ensure a flawless customer experience for speakers contracted by Lilly, from invitation to payment (zero complaints)
Have a monthly gazette to share Lilly information with speakers
Have a metric to evaluate speaker performance objectively
Identify needs for materials development
Attend at least 3 P2P or eP2Ps monthly, hybrid coverage 80% of speakers before year-end
Manage the annual cap
Responsible for all materials being accurately approved before any promotional event
Accountable for Independent Events from Main Societies Congresses to Small Participations: Ensure independent meetings where we participate are strategic and have a clear objective
Comply with all policies and procedures for independent events

Skills

Brand Strategy

Marketing

Customer Insights

HCP Engagement

Cross-functional Collaboration

Scientific Communication

Time Management

Organizational Skills

Strategic Planning

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free